{
    "nctId": "NCT05968677",
    "briefTitle": "Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer Patients",
    "officialTitle": "Pragmatic, Controlled, Single-Center, Randomized Clinical Trial to Evaluate the Effect of Supplementation With an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Mean change from baseline in High-Sensitivity Troponin Levels as a serological marker of chemotherapy cardiotoxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of non-metastatic ductal breast cancer\n* Post-menopausal women\n* Chemotherapy with Doxorubicin or Epirubicin, with or without Cyclophosphamide, scheduled as adjuvant or neo-adjuvant\n* Written informed consent\n* Independent oral feeding\n* Must be able to carry out periodic visits\n\nExclusion Criteria:\n\n* Artificial feeding\n* Eastern Cooperative Oncology Group (ECOG) performance status \\>2\n* Impossibility to take the foreseen measurements\n* Other tumor pathologies\n* Previous therapy with Doxorubicin or Epirubicin\n* Ongoing treatment with molecular targeted therapies\n* Previous chronic renal, hepatic or cardiac insufficiency\n* History of mental disorders\n* Known allergies or intolerances to any study product ingredient\n* Participation in other interventional clinical trials in the past three months",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}